isoniazid has been researched along with rifamycins in 61 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 19 (31.15) | 18.7374 |
1990's | 18 (29.51) | 18.2507 |
2000's | 9 (14.75) | 29.6817 |
2010's | 9 (14.75) | 24.3611 |
2020's | 6 (9.84) | 2.80 |
Authors | Studies |
---|---|
McNicol, M | 1 |
Dinh-Xuan, AT; Grosset, J; Lebeaut, A; Parrot, R; Pretet, S; Truffot, C | 1 |
Aber, VR; Allen, BW; Chan, SL; Felmingham, D; Girling, DJ; Ma, WK; Mitchison, DA; Yew, WW | 1 |
Breda, M; Carpentieri, M; Efthymiopoulos, C; Pianezzola, E; Rimoldi, R; Sassella, D; Strolin Benedetti, M | 1 |
Clavel-Sérès, S; Cruaud, P; Dwyer, B; Goh, KS; Jeantils, V; Rastogi, N; Ross, BC | 1 |
Hjelm, U; Hoffner, SE; Kaustová, J; Kubín, M | 1 |
Dautzenberg, B; Grosset, J; Katlama, C; Mignon, A; Parrot, R; Perronne, C; Rozenbaum, W; Truffot, C | 1 |
Dwyer, B; Grayson, L; Hoy, J; Lucas, R; Mijch, A; Sandland, M | 1 |
Alimova, LV; Maĭovetskaia, NS; Severina, MV; Shimko, NP | 1 |
Iusukhno, EE; Khomenko, VV; Petrovich, DI; Porokhnia, VV; Skvira, VP | 1 |
Berezovskiĭ, BA; Osiĭnskiĭ, IIu | 1 |
Bolinger, AM; Levin, RH | 1 |
Eichelbaum, M; Jensen, JC; Loos, U; Mikus, G; Musch, E; Schwabe, HK | 1 |
Gikalov, I; Hoigné, R; Keller, M; Klein, U | 1 |
Levitt, T | 1 |
Baur, O; Delepierre, F; Fontaine, JL; Haik, M; Lellouch, A; Rullière, R; Samama, M | 1 |
Boman, G | 1 |
Ayoub, A | 1 |
Djurisić, M; Jovanović, M; Vlahović, M | 1 |
Cynamon, MH; Grossi, MA; Klemens, SP | 1 |
Lüthy, R; Opravil, M; Salfinger, M; Zaugg, M | 1 |
Carosi, G; Matteelli, A | 1 |
Cynamon, MH; Klemens, SP | 1 |
Amitani, R; Kuze, F; Murayama, T; Suzuki, K; Tanaka, E; Yamamoto, T | 1 |
Berning, SE; Peloquin, CA | 1 |
Brooks, JV; Orme, IM | 1 |
Chase, SE; Chmielewski, AJ; Cynamon, MH; Lenaerts, AM | 1 |
Kotecha, JS; Rathod, IS; Savale, SS; Shah, PB; Shah, SA; Shishoo, CJ | 1 |
Cynamon, MH; DeStefano, MS; Shoen, CM | 1 |
Chase, SE; Cynamon, MH; Lenaerts, AM | 1 |
Dietze, R; Eisenach, K; Ellner, JJ; Johnson, JL; Maciel, E; Palaci, M; Phillips, M; Rocha, LM; Rose, L; Teixeira, L; Wallis, RS; Wells, C | 1 |
Dietze, R; Eisenach, K; Ellner, JJ; Johnson, JL; Palaci, M; Rocha, LM; Rose, L; Teixeira, L; Wells, C | 1 |
MARCATILI, S; NINNI, A | 1 |
DADDI, G | 1 |
COMENALE, D; FILLA, E; ROSSI, F | 1 |
CURCI, G; MAURO, G | 1 |
Benator, D; Burman, W; Hodge, T; Jones, B; Khan, A; Peloquin, CA; Silva-Trigo, C; Vernon, A; Weiner, M; Zhao, Z | 1 |
Azaev, MSh; Baranova, OI; Blinova, LN; Bodnev, SA; Boldyrev, AN; Filipenko, ML; Ivlev-Duntau, AP; Kinsht, VN; Krasnov, VA; Kurunov, IuN; Medvedeva, EV; Norkina, OV; Pasechnikov, AD; Sivkov, AIu; Tat'kov, SI | 1 |
Azeeza, S; Kamal, A; Malik, MS; Rao, MV; Shaik, AA | 1 |
Mitchison, DA | 1 |
Cavanaugh, JS; Cegielski, JP; Click, ES; Kurbatova, EV; Yuen, CM | 1 |
Heysell, SK; Reynolds, J | 1 |
Farhan, N; Kawde, AN; Temerk, Y | 1 |
Abdullahi, LH; Meintjes, G; Rockwood, N; Wilkinson, RJ | 1 |
Alsdurf, H; Getahun, H; Hill, PC; Matteelli, A; Menzies, D | 1 |
Gold, B; Jacobs, WR; Jiang, X; Kaminski, L; Mi, J; Nathan, CF; Park, S; Roberts, J; Saito, K; Shigyo, K; Somersan-Karakaya, S; Warrier, T; Weber, E | 1 |
Belknap, R; Chee, CBE; Reves, R; Zhang, Y | 1 |
Kammara, R; Lokesh, D; Parkesh, R | 1 |
Gao, CH; Hu, LH; Jia, SH; Jia, WZ; Tao, HL; Yang, M; Zhu, C | 1 |
Alameer, R; Almaghrabi, RS; Almohaizeie, A; Alrajhi, AA; Alshehri, N; Nizami, I; Omrani, AS | 1 |
Benedetti, A; Campbell, JR; Churchyard, G; Menzies, D; Ortiz-Brizuela, E; Oxlade, O; Yanes-Lane, M | 1 |
Dorman, SE; Shah, M | 1 |
Barnes, GL; Chaisson, RE; Gupta, A; Martinson, NA; Moulton, LH; Msandiwa, R; Singh, P | 1 |
Fortún, J; Navas, E | 1 |
11 review(s) available for isoniazid and rifamycins
Article | Year |
---|---|
Extrapulmonary and disseminated infections due to Mycobacterium malmoense: case report and review.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Antitubercular Agents; Clofazimine; Gastrointestinal Diseases; Homosexuality; Humans; Isoniazid; Lung Diseases; Lymphadenitis; Male; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Rifabutin; Rifamycins; Tenosynovitis | 1993 |
Prophylaxis for tuberculosis in Europe--ongoing research.
Topics: AIDS-Related Opportunistic Infections; Antibiotics, Antitubercular; Antitubercular Agents; Clinical Trials as Topic; Cost-Benefit Analysis; Europe; Humans; Isoniazid; Rifamycins; Tuberculosis | 1996 |
Drugs for tuberculosis.
Topics: Antibiotics, Antitubercular; Antiretroviral Therapy, Highly Active; Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Female; HIV Infections; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Pregnancy; Rifabutin; Rifamycins; Tuberculosis | 2004 |
Efforts towards the development of new antitubercular agents: potential for thiolactomycin based compounds.
Topics: Animals; Antitubercular Agents; Drug Design; Ethambutol; Isoniazid; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Physiological Phenomena; Pyrazinamide; Rifamycins; Streptomycin; Thiophenes; Tuberculosis; Tuberculosis, Pulmonary | 2008 |
Understanding pharmacokinetics to improve tuberculosis treatment outcome.
Topics: Antitubercular Agents; Diabetes Mellitus; Drug Monitoring; Ethambutol; HIV Infections; Humans; Isoniazid; Microbial Sensitivity Tests; Pyrazinamide; Rifamycins; Treatment Outcome; Tuberculosis; Tuberculosis, Pulmonary | 2014 |
Risk Factors for Acquired Rifamycin and Isoniazid Resistance: A Systematic Review and Meta-Analysis.
Topics: AIDS-Related Opportunistic Infections; Antitubercular Agents; Drug Resistance, Bacterial; Humans; Isoniazid; Rifamycins; Risk; Tuberculosis | 2015 |
The cascade of care in diagnosis and treatment of latent tuberculosis infection: a systematic review and meta-analysis.
Topics: Antirheumatic Agents; Antitubercular Agents; Continuity of Patient Care; Humans; Isoniazid; Latent Tuberculosis; Lost to Follow-Up; Rifamycins | 2016 |
Latent tuberculosis infection: Opportunities and challenges.
Topics: Antitubercular Agents; Host-Pathogen Interactions; Humans; Interferon-gamma Release Tests; Isoniazid; Latent Tuberculosis; Medication Adherence; Rifamycins; Tuberculin Test | 2018 |
Tuberculosis preventive therapy for people living with HIV: A systematic review and network meta-analysis.
Topics: Adolescent; Adult; Aged; Anti-Retroviral Agents; Antitubercular Agents; Child; Child, Preschool; Coinfection; Female; HIV Infections; HIV Long-Term Survivors; Humans; Infant; Isoniazid; Male; Middle Aged; Preventive Health Services; Rifamycins; Risk Assessment; Risk Factors; Treatment Outcome; Tuberculosis; Young Adult | 2021 |
Latent Tuberculosis Infection.
Topics: Adult; Algorithms; Antitubercular Agents; Child; Drug Therapy, Combination; Humans; Isoniazid; Latent Tuberculosis; Male; Mycobacterium tuberculosis; Rifamycins; Risk Factors; Tuberculin Test | 2021 |
Latent tuberculosis infection: approach and therapeutic schemes.
Topics: Humans; Interferon-gamma Release Tests; Isoniazid; Latent Tuberculosis; Rifamycins; Tuberculosis | 2022 |
11 trial(s) available for isoniazid and rifamycins
Article | Year |
---|---|
Controlled clinical trial of four 6-month regimens of chemotherapy for pulmonary tuberculosis. Second report. Second East African/British Medical Research Council Study.
Topics: Adolescent; Clinical Trials as Topic; Drug Therapy, Combination; Follow-Up Studies; Humans; Isoniazid; Pyrazinamide; Rifamycins; Streptomycin; Time Factors; Tuberculosis, Pulmonary | 1976 |
Combined chemotherapy including rifabutin for rifampicin and isoniazid resistant pulmonary tuberculosis. G.E.T.I.M. (Group for the Study and Treatment of Resistant Mycobacterial Infection).
Topics: Adult; Antitubercular Agents; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Humans; Isoniazid; Male; Mycobacterium tuberculosis; Rifabutin; Rifampin; Rifamycins; Time Factors; Tuberculosis, Pulmonary | 1992 |
The early bactericidal activity of rifabutin measured by sputum viable counts in Hong Kong patients with pulmonary tuberculosis.
Topics: Adolescent; Adult; Antitubercular Agents; Colony Count, Microbial; Dose-Response Relationship, Drug; Hong Kong; Humans; Isoniazid; Mycobacterium tuberculosis; Rifabutin; Rifampin; Rifamycins; Sputum; Tuberculosis, Pulmonary | 1992 |
A controlled study of rifabutin and an uncontrolled study of ofloxacin in the retreatment of patients with pulmonary tuberculosis resistant to isoniazid, streptomycin and rifampicin. Hong Kong Chest Service/British Medical Research Council.
Topics: Adult; Aged; Antitubercular Agents; Chronic Disease; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Ofloxacin; Rifabutin; Rifampin; Rifamycins; Sputum; Streptomycin; Treatment Outcome; Tuberculosis, Pulmonary | 1992 |
Rifabutin in combination with clofazimine, isoniazid and ethambutol in the treatment of AIDS patients with infections due to opportunist mycobacteria. Groupe d'Etude et de Traitement des Infections à Mycobacteries Résistantes.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antitubercular Agents; Clofazimine; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Male; Mycobacterium Infections; Opportunistic Infections; Prospective Studies; Rifabutin; Rifamycins | 1991 |
Pharmacokinetics of oral and intravenous rifampicin during chronic administration.
Topics: Administration, Oral; Adolescent; Adult; Aged; Biological Availability; Drug Therapy, Combination; Ethambutol; Female; Humans; Infusions, Parenteral; Isoniazid; Male; Metabolic Clearance Rate; Middle Aged; Rifampin; Rifamycins; Tuberculosis, Pulmonary | 1985 |
Controlled clinical trial of four short-course (6-month) regimens of chemotherapy for treatment of pulmonary tuberculosis. Second report.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Drug Resistance, Microbial; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Pyrazinamide; Radiography; Rifamycins; Streptomycin; Thioacetazone; Time Factors; Tuberculosis, Pulmonary | 1973 |
Inhibition of isoniazid-induced expression of Mycobacterium tuberculosis antigen 85 in sputum: potential surrogate marker in tuberculosis chemotherapy trials.
Topics: Acyltransferases; Antibiotics, Antitubercular; Antigens, Bacterial; Antitubercular Agents; Biomarkers; Colony Count, Microbial; Humans; Isoniazid; Kinetics; Recurrence; Rifampin; Rifamycins; Sputum; Tuberculosis | 2001 |
Safety and bactericidal activity of rifalazil in patients with pulmonary tuberculosis.
Topics: Adolescent; Adult; Antibiotics, Antitubercular; Antitubercular Agents; Colony Count, Microbial; Female; Hematologic Tests; Humans; Isoniazid; Kidney Function Tests; Liver Function Tests; Male; Rifamycins; Tuberculosis, Pulmonary | 2001 |
Association between acquired rifamycin resistance and the pharmacokinetics of rifabutin and isoniazid among patients with HIV and tuberculosis.
Topics: Adult; Antitubercular Agents; Area Under Curve; CD4 Lymphocyte Count; Directly Observed Therapy; Drug Resistance, Bacterial; Female; HIV Infections; Humans; Isoniazid; Male; Middle Aged; Multivariate Analysis; Mycobacterium tuberculosis; Recurrence; Rifabutin; Rifamycins; Risk Factors; Treatment Failure; Tuberculosis | 2005 |
Pregnancy in Women With HIV in a Tuberculosis Preventive Therapy Trial.
Topics: Antitubercular Agents; Contraceptive Agents; Drug Administration Schedule; Drug Therapy, Combination; Female; HIV Infections; Humans; Infant, Newborn; Isoniazid; Latent Tuberculosis; Pregnancy; Rifampin; Rifamycins; Tuberculosis | 2022 |
39 other study(ies) available for isoniazid and rifamycins
Article | Year |
---|---|
Treatment of tuberculosis.
Topics: Antitubercular Agents; Chemical and Drug Induced Liver Injury; Costs and Cost Analysis; Drug Hypersensitivity; Ethambutol; Female; Humans; Isoniazid; Optic Neuritis; Pregnancy; Rifamycins; Tuberculosis | 1979 |
A study of the effects of rifabutin on isoniazid pharmacokinetics and metabolism in healthy volunteers.
Topics: Acetylation; Adult; Anti-Bacterial Agents; Chromatography, High Pressure Liquid; Half-Life; Humans; Isoniazid; Male; Phenotype; Rifabutin; Rifamycins; Spectrophotometry, Ultraviolet | 1992 |
Emergence during unsuccessful chemotherapy of multiple drug resistance in a strain of Mycobacterium tuberculosis.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Antitubercular Agents; Bacteriophage Typing; Blotting, Southern; Clofazimine; Colony Count, Microbial; DNA, Bacterial; Drug Resistance, Microbial; Fluoroquinolones; Humans; Isoniazid; Lactams, Macrocyclic; Male; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Polymorphism, Restriction Fragment Length; Rifamycins; Tuberculosis, Pulmonary | 1992 |
Susceptibility of Mycobacterium kansasii to ethambutol and its combination with rifamycins, ciprofloxacin and isoniazid.
Topics: Ciprofloxacin; Drug Resistance, Microbial; Drug Synergism; Ethambutol; Isoniazid; Nontuberculous Mycobacteria; Rifamycins | 1992 |
[Management of INH and RFP-resistant refractory tuberculosis].
Topics: Drug Resistance; Female; Humans; Isoniazid; Male; Mycobacterium tuberculosis; Ofloxacin; Rifamycins; Tuberculosis, Pulmonary | 1991 |
Quadruple-drug therapy for Mycobacterium avium-intracellulare bacteremia in AIDS patients.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-Infective Agents; Clofazimine; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Male; Middle Aged; Mycobacterium avium-intracellulare Infection; Rifabutin; Rifamycins; Sepsis | 1990 |
[Rifabutine in the treatment of mycobacterial infections resistant to rifampicin. Preliminary results. Group for the Study and Treatment of Resistant Mycobacterial Infections (GETIM)].
Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium avium-intracellulare Infection; Mycobacterium Infections; Mycobacterium Infections, Nontuberculous; Ofloxacin; Rifabutin; Rifampin; Rifamycins; Tuberculosis, Pulmonary | 1989 |
[Polychemotherapy of patients with chronic destructive forms of pulmonary tuberculosis in interregional tuberculosis hospitals].
Topics: Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Ethionamide; Humans; Isoniazid; Rifamycins; Streptomycin; Time Factors; Tuberculosis, Pulmonary | 1989 |
[Experience with intensive short-term chemotherapy of patients with recently diagnosed destructive pulmonary tuberculosis].
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Female; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Rifamycins; Streptomycin; Time Factors; Tuberculosis, Pulmonary | 1989 |
[Effectiveness of intermittent chemotherapy in the combined treatment of patients with recently diagnosed destructive tuberculosis of the lungs].
Topics: Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Ethionamide; Female; Humans; Isoniazid; Male; Middle Aged; Rifamycins; Streptomycin; Time Factors; Tuberculosis, Pulmonary | 1989 |
Treatment of nontuberculous mycobacterial infections in pediatric patients.
Topics: Acquired Immunodeficiency Syndrome; Anti-Bacterial Agents; Anti-Infective Agents; Child, Preschool; Ethambutol; Female; Humans; Infant; Isoniazid; Male; Microbial Sensitivity Tests; Mycobacterium avium; Mycobacterium Infections; Rifabutin; Rifampin; Rifamycins; Streptomycin | 1988 |
[Drug monitoring in the medical ward of a regional hospital].
Topics: Adult; Ampicillin; Anticoagulants; Antidepressive Agents; Central Nervous System Stimulants; Chemical and Drug Induced Liver Injury; Digitalis Glycosides; Drug Eruptions; Drug Hypersensitivity; Drug Synergism; Female; Humans; Hypnotics and Sedatives; Isoniazid; Male; Middle Aged; Monitoring, Physiologic; Penicillins; Rifamycins; Sulfamethoxazole; Time Factors; Tranquilizing Agents; Trimethoprim | 1972 |
[Shortening of tuberculosis treatment].
Topics: Animals; Drug Synergism; Humans; Isoniazid; Methods; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifamycins; Time Factors; Tuberculosis, Pulmonary | 1972 |
[Massive pulmonary embolism during bacillary tuberculous pneumonia. Remarkable effects of streptokinase].
Topics: Adult; Angiography; Electrocardiography; Ethambutol; Hematoma; Heparin; Humans; Isoniazid; Male; Phlebitis; Phlebography; Pulmonary Embolism; Radionuclide Imaging; Rifamycins; Streptokinase; Tachycardia; Tuberculosis, Pulmonary; Vena Cava, Inferior; Vitamin K | 1973 |
Serum concentration and half-life of rifampicin after simultaneous oral administration of aminosalicylic acid or isoniazid.
Topics: Adult; Aged; Aminosalicylic Acids; Biological Assay; Drug Interactions; Female; Half-Life; Humans; Isoniazid; Male; Middle Aged; Rifamycins; Sarcina; Sex Factors; Statistics as Topic; Time Factors; Tuberculosis | 1974 |
[Antitubercular agents and hepatic complications].
Topics: Adult; Aged; Antitubercular Agents; Biotransformation; Chemical and Drug Induced Liver Injury; Drug Therapy, Combination; Female; Humans; Isoniazid; Male; Middle Aged; Rifamycins | 1984 |
[The effect of a combination of INH, Rifadin and Miambutol in generalized tuberculosis].
Topics: Animals; Drug Combinations; Ethambutol; Guinea Pigs; Isoniazid; Rifamycins; Tuberculosis | 1981 |
Activity of KRM-1648, a new benzoxazinorifamycin, against Mycobacterium tuberculosis in a murine model.
Topics: Animals; Antibiotics, Antitubercular; Drug Therapy, Combination; Female; Isoniazid; Mice; Pyrazinamide; Rifabutin; Rifampin; Rifamycins; Tuberculosis | 1994 |
Activity of KRM-1648 in combination with isoniazid against Mycobacterium tuberculosis in a murine model.
Topics: Animals; Antibiotics, Antitubercular; Colony Count, Microbial; Drug Therapy, Combination; Female; Isoniazid; Lung; Mice; Mycobacterium tuberculosis; Rifampin; Rifamycins; Spleen; Time Factors; Tuberculosis | 1996 |
In vitro bactericidal and in vivo therapeutic activities of a new rifamycin derivative, KRM-1648, against Mycobacterium tuberculosis.
Topics: Animals; Antibiotics, Antitubercular; Antitubercular Agents; Dose-Response Relationship, Drug; Drug Combinations; Ethambutol; Isoniazid; Male; Mice; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Rifamycins; Tuberculosis | 1996 |
Advice on treatment of Mycobacterium avium complex infection.
Topics: Antitubercular Agents; Clarithromycin; Drug Interactions; Humans; Isoniazid; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Rifamycins | 1997 |
Evaluation of once-weekly therapy for tuberculosis using isoniazid plus rifamycins in the mouse aerosol infection model.
Topics: Aerosols; Animals; Antitubercular Agents; Drug Administration Schedule; Drug Therapy, Combination; Female; Isoniazid; Mice; Mice, Inbred C57BL; Rifamycins; Tuberculosis | 1998 |
Evaluation of rifapentine in long-term treatment regimens for tuberculosis in mice.
Topics: Animals; Antibiotics, Antitubercular; Antitubercular Agents; Disease Models, Animal; Drug Therapy, Combination; Evaluation Studies as Topic; Female; Isoniazid; Mice; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Rifamycins; Tuberculosis | 1999 |
Stability of rifampicin in dissolution medium in presence of isoniazid.
Topics: Antitubercular Agents; Chromatography, Thin Layer; Drug Compounding; Drug Stability; Hydrochloric Acid; Hydrogen-Ion Concentration; Isoniazid; Regression Analysis; Reproducibility of Results; Rifampin; Rifamycins; Sensitivity and Specificity; Solubility; Spectrophotometry, Ultraviolet | 1999 |
Durable cure for tuberculosis: rifalazil in combination with isoniazid in a murine model of Mycobacterium tuberculosis infection.
Topics: Animals; Antitubercular Agents; Colony Count, Microbial; Dexamethasone; Disease Models, Animal; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Isoniazid; Lung; Mice; Mycobacterium tuberculosis; Rifamycins; Spleen; Treatment Outcome; Tuberculosis, Pulmonary | 2000 |
Evaluation of rifalazil in a combination treatment regimen as an alternative to isoniazid-rifampin therapy in a mouse tuberculosis model.
Topics: Animals; Antitubercular Agents; Colony-Forming Units Assay; Disease Models, Animal; Drug Therapy, Combination; Ethambutol; Female; Isoniazid; Mice; Pyrazinamide; Rifampin; Rifamycins; Tuberculosis | 2000 |
Acquired rifamycin resistance in persons with advanced HIV disease being treated for active tuberculosis with intermittent rifamycin-based regimens.
Topics: AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antibiotics, Antitubercular; Antiretroviral Therapy, Highly Active; Drug Interactions; Drug Resistance, Bacterial; HIV Infections; Humans; Isoniazid; Rifamycins; Tuberculosis | 2002 |
[RESEARCH ON THE BEHAVIOR OF TUBERCULIN ALLERGY DURING TREATMENT WITH RIFAMYCIN SV].
Topics: Animals; Biomedical Research; Guinea Pigs; Hypersensitivity; Isoniazid; Pharmacology; Research; Rifamycins; Tuberculin; Tuberculin Test; Tuberculosis; Tuberculosis, Pulmonary | 1964 |
[ASPECTS OF ANTI-INFECTION THERAPY IN ADVANCED AGE].
Topics: Anti-Bacterial Agents; Biomedical Research; Chloramphenicol; Geriatrics; Infections; Isoniazid; Parabiosis; Penicillins; Pharmacology; Rats; Research; Rifamycins; Streptomycin; Sulfamethoxypyridazine; Sulfathiazoles; Tetracycline | 1964 |
[CHEMO-ANTIBIOTIC THERAPY OF TUBERCULOSIS IN DIABETICS AND ITS REPERCUSSIONS ON GLUCIDE METABOLISM].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Antitubercular Agents; Blood Glucose; Carbohydrate Metabolism; Cycloserine; Diabetes Mellitus; Drug Tolerance; Ethionamide; Humans; Isoniazid; Kanamycin; Pharmacology; Pyrazinamide; Rifamycins; Streptomycin; Thiosemicarbazones; Tuberculosis; Tuberculosis, Pulmonary | 1964 |
[FIRST EXPERIENCES IN THE USE OF RIFAMYCIN SV ASSOCIATED WITH PAS USING THE METHOD OF VENOUS PERFUSION. CLINICAL CONTRIBUTION].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Drug Therapy; Humans; Infusions, Parenteral; Isoniazid; Radiography, Thoracic; Rifamycins; Streptomycin; Tomography; Tuberculosis; Tuberculosis, Pulmonary | 1964 |
[Molecular and genetic characterization of rifampicin- and/or izoniazid-resistent strains of M. tuberculosis, isolated in Novosibirsk and Tomsk regions].
Topics: Antitubercular Agents; Drug Resistance, Bacterial; Genome, Bacterial; Humans; Isoniazid; Minisatellite Repeats; Mycobacterium tuberculosis; Polymorphism, Genetic; Retrospective Studies; Rifamycins; Siberia; Tuberculosis | 2005 |
Pharmacokinetic/pharmacodynamic parameters and the choice of high-dosage rifamycins.
Topics: Acetylation; Animals; Antitubercular Agents; Area Under Curve; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Humans; Isoniazid; Mice; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifamycins; Sputum; Treatment Outcome; Tuberculosis | 2012 |
Association between Mycobacterium tuberculosis complex phylogenetic lineage and acquired drug resistance.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Bacterial Typing Techniques; Child; Child, Preschool; Epidemiological Monitoring; Female; Fluoroquinolones; Humans; Infant; Infant, Newborn; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Mycobacterium bovis; Mycobacterium tuberculosis; Phylogeny; Prevalence; Rifamycins; Tuberculosis, Multidrug-Resistant; United States | 2013 |
Adsorptive stripping voltammetry of antibiotics rifamycin SV and rifampicin at renewable pencil electrodes.
Topics: Adsorption; Anti-Bacterial Agents; Electrochemistry; Electrodes; Equipment Reuse; Humans; Isoniazid; Reproducibility of Results; Rifampin; Rifamycins | 2014 |
Rifamycin action on RNA polymerase in antibiotic-tolerant
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Bacterial Proteins; DNA-Directed RNA Polymerases; Drug Resistance, Bacterial; Humans; Isoniazid; Mutation; Mycobacterium tuberculosis; Rifamycins; Thioridazine; Tuberculosis | 2017 |
Bifidobacterium adolescentis is intrinsically resistant to antitubercular drugs.
Topics: Antitubercular Agents; Bacterial Proteins; Bifidobacterium adolescentis; Binding Sites; Drug Resistance, Multiple, Bacterial; Isoniazid; Microbial Sensitivity Tests; Molecular Docking Simulation; Mutation; Protein Binding; Protein Domains; Pyrazinamide; Rifamycins; RNA Polymerase II | 2018 |
Cd(II)-binding transcriptional regulator interacts with isoniazid and regulates drug susceptibility in mycobacteria.
Topics: Antitubercular Agents; Bacterial Proteins; Cadmium; Drug Resistance, Bacterial; Ethambutol; Gene Expression Regulation, Bacterial; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium; Mycobacterium tuberculosis; Rifamycins; Transcription Factors | 2021 |
Successful Use of Rifamycin-Sparing Regimens for the Treatment of Active Tuberculosis in Lung Transplant Recipients.
Topics: Ethambutol; Humans; Isoniazid; Lung; Lung Transplantation; Moxifloxacin; Pyrazinamide; Rifamycins; Transplant Recipients; Treatment Outcome; Tuberculosis | 2021 |